Lipocine Inc.

Lipocine Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
21.26 M
Public Float
20.02 M
Lipocine Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.55
Market Cap
$47.43 M
Shares Outstanding
24.58 M
Public Float
20.02 M

Profile

Address
675 Arapeen Drive
Salt Lake City Utah 84108
United States
Employees -
Website http://www.lipocine.com
Updated 07/08/2019
Lipocine, Inc. is a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded on July 24, 2013 and is headquartered in Salt Lake City, UT.

Financials

View All
Created with Highcharts 5.0.14Lipocine Inc.Net Income. Fiscal year is January-December. All values USD Thousands.10 59010 59020 37220 37218 20818 20818 97118 97120 98220 98211 66011 66020132014201520162017201805k10k15k20k25k

Mahesh V. Patel
Chairman, President & Chief Executive Officer
John W. Higuchi
Director